Key facts
- It has raised $16.1M; the latest was Later Stage VC ($9.9M) in Dec 2025.
- Notable investors include Tech Incubator Program for Startup, SBI Investment, European Commission, IBK Changgong, STIC Ventures — 16 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Plcoskin
- ·The full record, as it builds
Funding rounds
No funding rounds for Plcoskin are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Plcoskin
Developer of reconstructive medical devices designed to offer a two-track strategy encompassing breast reconstruction and fillers. The company's devices offer skin regenerating sheets mainly for patients who have breast tissue from breast cancer, which reduces reconstruction surgery costs, enabling patients to have a safer surgery.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2017
- Employees
- 24
- Website
- plcoskin.com/
- Ownership
- Privately Held (backing)
Plcoskin doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Plcoskin shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Plcoskin in its N-PORT filings yet. We sweep new filings monthly.